Next, we examined whether SMA could exert anti-proliferative activity in A549 human non-small cell lung cancer cells (NSCLC), which possess mutant APC and wild type β-catenin similar to HT29 colon cancer cells. This evidence concerns the gene SMN1 and non-small cell lung carcinoma.